Antiverse

Antiverse is a generative AI company with programmable cell lines to engineer antibodies for challenging targets. Post-revenue; partnered with two Top 20 pharma; contracts with potential milestones and royalties; human and in vivo data on an internal program. Raised $9M from US and UK-based investors.